Parenteral nutrition induced cholestatic jaundice in premature infants Neonatal Diseases Neonatal jaundice from other and unspecified causes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Preterm < 34 weeks of gestational age who admitted to NICU and sick newborn ward at Srinagarind hospital 2. Post natal age not more than 1 month 3. Meet indication for parenteral nutrition 4. Parent permitted to be the participant
Exclusion criteria
Exclusion criteria: 1. Risk for bleeding tendency: Platelet less than 60,000 /mm3, coagulopathy 2. Risk for hepatic dysfunction: severe birth asphyxia 3. Fatal chromosome abnormality (Trisomy 13, 15, 18) 5. Direct bilirubin more than 2 mg/dl before start experiment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total bilirubin and direct bilirubin. All outcomes will be assessed at baseline and at 2 weeks after start parenteral nutrition and then follow up weekly until stop parenteral nutrition. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Alanine Aminotransferase (ALT) 2. Aspartate Aminotransferase (AST) 3. Alkaline Phosphatase (ALP) All outcomes will be assessed at baseline and at 2 weeks after start parenteral nutrition and then follow up weekly until stop parenteral nutrition. | — |
Countries
Thailand